4-(Naphthalen-2-yl)-N-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-amine hydrobromide

Catalog No. :
ACFCAH383
CAS No. :
1274904-26-5
Molecular Formula :
C20H14BrF3N2OS
Molecular Weight :
467.31

IUPAC Name:4-(naphthalen-2-yl)-N-(4-(trifluoromethoxy)phenyl)thiazol-2-amine hydrobromide

4-(Naphthalen-2-yl)-N-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-amine hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Naphthalen-2-yl)-N-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-amine hydrobromide
IUPAC Name4-(naphthalen-2-yl)-N-(4-(trifluoromethoxy)phenyl)thiazol-2-amine hydrobromide
MDL No.MFCD01114553
Molecular FormulaC20H14BrF3N2OS
Molecular Weight467.31
SMILESFC(F)(F)OC1=CC=C(NC2=NC(C3=CC=C4C=CC=CC4=C3)=CS2)C=C1.[H]Br
InChI KeyVSAHISZOWQPZEI-UHFFFAOYSA-N
Synonym(4-(2-NAPHTHYL)(2,5-THIAZOLYL))(4-(TRIFLUOROMETHOXY)PHENYL)AMINE, HYDROBROMIDE
CAS No.1274904-26-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFCAH383 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYNSW793 route compound structure diagram
    ACYNSW793142229-74-1 In Stock
  2. Plus
  3. ACOVHK583 route compound structure diagram
    ACOVHK583613-54-7 In Stock
  4. Then
  5. ACFCAH383 route product structure diagram
    ACFCAH3831274904-26-5
Inquiry

2. ACFCAH383 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  4. Then
  5. ACFCAH383 route product structure diagram
    ACFCAH3831274904-26-5
Inquiry

Comments (0)